These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 6997872
21. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone. Leyer S, Gattner HG, Leithäuser M, Brandenburg D, Wollmer A, Höcker H. Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184 [Abstract] [Full Text] [Related]
22. Impaired negative cooperativity of the semisynthetic analogues human [LeuB24]- and [LeuB25]-insulins. Keefer LM, Piron MA, De Meyts P, Gattner HG, Diaconescu C, Saunders D, Brandenburg D. Biochem Biophys Res Commun; 1981 Jun 16; 100(3):1229-36. PubMed ID: 7023479 [No Abstract] [Full Text] [Related]
23. Structure-function relationships of des-(B26-B30)-insulin. Spoden M, Gattner HG, Zahn H, Brandenburg D. Int J Pept Protein Res; 1995 Jun 16; 46(3-4):221-7. PubMed ID: 8537175 [Abstract] [Full Text] [Related]
24. The use of Fmoc-Lys(Pac)-OH and penicillin G acylase in the preparation of novel semisynthetic insulin analogs. Záková L, Zyka D, Jezek J, Hanclová I, Sanda M, Brzozowski AM, Jirácek J. J Pept Sci; 2007 May 16; 13(5):334-41. PubMed ID: 17436342 [Abstract] [Full Text] [Related]
25. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor. Kurose T, Pashmforoush M, Yoshimasa Y, Carroll R, Schwartz GP, Burke GT, Katsoyannis PG, Steiner DF. J Biol Chem; 1994 Nov 18; 269(46):29190-7. PubMed ID: 7961885 [Abstract] [Full Text] [Related]
29. Further studies on the three-step-increase in activity due to the aromatic amino acids B24-26 (-Phe-Phe-Tyr-). Weitzel G, Bauer FU, Eisele K. Hoppe Seylers Z Physiol Chem; 1976 Feb 18; 357(2):187-200. PubMed ID: 1254246 [Abstract] [Full Text] [Related]
30. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions. Mirmira RG, Nakagawa SH, Tager HS. J Biol Chem; 1991 Jan 25; 266(3):1428-36. PubMed ID: 1988428 [Abstract] [Full Text] [Related]
32. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat. Stümpel F, Hartmann H, Brandenburg D, Creutzfeldt W. Diabetes Res Clin Pract; 1990 Jul 25; 9(3):257-64. PubMed ID: 2226126 [Abstract] [Full Text] [Related]
34. Shortened insulin with enhanced in vitro potency. Casaretto M, Spoden M, Diaconescu C, Gattner HG, Zahn H, Brandenburg D, Wollmer A. Biol Chem Hoppe Seyler; 1987 Jun 25; 368(6):709-16. PubMed ID: 3304338 [Abstract] [Full Text] [Related]
35. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Shoelson S, Fickova M, Haneda M, Nahum A, Musso G, Kaiser ET, Rubenstein AH, Tager H. Proc Natl Acad Sci U S A; 1983 Dec 25; 80(24):7390-4. PubMed ID: 6424111 [Abstract] [Full Text] [Related]
38. Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity. Kobayashi M, Ohgaku S, Iwasaki M, Maegawa H, Shigeta Y, Inouye K. Biochem J; 1982 Sep 15; 206(3):597-603. PubMed ID: 6756393 [Abstract] [Full Text] [Related]
39. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation. Mirmira RG, Tager HS. J Biol Chem; 1989 Apr 15; 264(11):6349-54. PubMed ID: 2649499 [Abstract] [Full Text] [Related]